Literature DB >> 12213978

Elevations in cardiac troponin measurements: false false-positives: the real truth.

A S Jaffe1.   

Abstract

The development of assays for troponin markers has improved cardiovascular diagnosis. However, because the assays are so sensitive and specific, elevations are often detected in patients without overt coronary artery disease. Some would like to attribute such elevations to biological "false positives." That is rarely the case. There can be analytic false positives but most such elevations are indicative of subtle degrees of cardiac injury, many not related to ischemic heart disease. The spectrum of such increases and their potential etiologies are elaborated in this article.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12213978     DOI: 10.1385/ct:1:2:087

Source DB:  PubMed          Journal:  Cardiovasc Toxicol        ISSN: 1530-7905            Impact factor:   3.231


  16 in total

1.  Antithrombotic strategies and outcomes in acute coronary syndrome with atrial fibrillation.

Authors:  Alanna M Chamberlain; Bernard J Gersh; Roger M Mills; Winslow Klaskala; Alvaro Alonso; Susan A Weston; Véronique L Roger
Journal:  Am J Cardiol       Date:  2015-01-31       Impact factor: 2.778

Review 2.  Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury.

Authors:  Rakesh Malhotra; Edward D Siew
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-08       Impact factor: 8.237

3.  Prognostic value of cardiac troponin T after myocardial infarction: a contemporary community experience.

Authors:  Yariv Gerber; Allan S Jaffe; Susan A Weston; Ruoxiang Jiang; Véronique L Roger
Journal:  Mayo Clin Proc       Date:  2012-03       Impact factor: 7.616

4.  Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.

Authors:  William S Jenkins; Véronique L Roger; Allan S Jaffe; Susan A Weston; Omar F AbouEzzeddine; Ruoxiang Jiang; Sheila M Manemann; Maurice Enriquez-Sarano
Journal:  Am J Med       Date:  2017-03-23       Impact factor: 4.965

5.  Trends in incidence, severity, and outcome of hospitalized myocardial infarction.

Authors:  Véronique L Roger; Susan A Weston; Yariv Gerber; Jill M Killian; Shannon M Dunlay; Allan S Jaffe; Malcolm R Bell; Jan Kors; Barbara P Yawn; Steven J Jacobsen
Journal:  Circulation       Date:  2010-02-08       Impact factor: 29.690

Review 6.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

7.  Atrial fibrillation in myocardial infarction patients: Impact on health care utilization.

Authors:  Alanna M Chamberlain; Suzette J Bielinski; Susan A Weston; Winslow Klaskala; Roger M Mills; Bernard J Gersh; Alvaro Alonso; Véronique L Roger
Journal:  Am Heart J       Date:  2013-08-17       Impact factor: 4.749

8.  Fall Risk and Outcomes Among Patients Hospitalized With Cardiovascular Disease in the Community.

Authors:  Sheila M Manemann; Alanna M Chamberlain; Cynthia M Boyd; Donna M Miller; Kimberly L Poe; Andrea Cheville; Susan A Weston; Ellen E Koepsell; Ruoxiang Jiang; Véronique L Roger
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-08

9.  Increased cardiac troponin I on admission predicts in-hospital mortality in acute pulmonary embolism.

Authors:  L La Vecchia; F Ottani; L Favero; G L Spadaro; A Rubboli; C Boanno; G Mezzena; A Fontanelli; A S Jaffe
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

10.  Association Between Atrial Fibrillation and Costs After Myocardial Infarction: A Community Study.

Authors:  Bijan J Borah; Véronique L Roger; Roger M Mills; Susan A Weston; Stephanie S Anderson; Alanna M Chamberlain
Journal:  Clin Cardiol       Date:  2015-09-07       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.